In murine models, depletion of CD4+FoxP3+ Tregs enhances tumor rejection and improves therapeutic responses to cancer vaccines by promoting the function of CD8+ cytotoxic T lymphocytes [74]. Here, FOXP3 is linked to neoplasm.